tradingkey.logo
tradingkey.logo
Search

Aligos Therapeutics Inc

ALGS
Add to Watchlist
4.230USD
-0.090-2.08%
Close 07-31 16:00ETQuotes delayed by 15 min
26.18MMarket Cap
LossP/E TTM

ALGS Financials

See Aligos Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Aligos Therapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-1.07
Revenue / Forecast
--/18.24M
Period
FY2025 Earnings
Revenue(YoY)
2.19M
-44.59%
EPS(YoY)
-2.45
88.31%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-143.22%-2.21
85.37%-1.91
0.95%-3.04
-289.49%-1.53
191.81%5.12
-20.51%-13.08
70.39%-3.07
107.44%0.81
58.27%-5.58
15.04%-10.85
---10.37
---10.87
---13.37
---12.77
---43.47
----
----
----
----
----
Revenue
809.97%2.83M
-73.13%169.00K
-41.61%741.00K
-9.05%965.00K
-68.46%311.00K
-76.54%629.00K
-60.82%1.27M
-84.59%1.06M
-63.79%986.00K
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
863.76%3.54M
167.14%4.11M
139.03%3.69M
182.53%2.57M
--367.00K
--1.54M
--1.54M
Net Profit
-153.47%-23.04M
75.80%-19.88M
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
Net Margin
-105.88%-814.13%
9.93%-11763.91%
-180.43%-4256.01%
-444.62%-1643.83%
491.84%13854.66%
-1155.38%-13060.41%
-172.47%-1517.65%
274.80%477.00%
-319.43%-3535.80%
-68.13%-1040.36%
---556.99%
---272.89%
---843.00%
---618.77%
---715.14%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
20.39%0.13%
-27.34%0.16%
-42.69%0.13%
-37.56%0.12%
-39.21%0.11%
41.72%0.23%
-20.67%0.23%
-24.38%0.19%
-32.49%0.17%
-30.97%0.16%
--0.29%
--0.25%
--0.26%
--0.23%
--0.19%
----
----
----
----
----
Revenue
809.97%2.83M
-73.13%169.00K
-41.61%741.00K
-9.05%965.00K
-68.46%311.00K
-76.54%629.00K
-60.82%1.27M
-84.59%1.06M
-63.79%986.00K
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
863.76%3.54M
167.14%4.11M
139.03%3.69M
182.53%2.57M
--367.00K
--1.54M
--1.54M
Operating profit
-39.94%-26.93M
-33.31%-21.81M
-40.88%-28.36M
29.71%-18.57M
12.71%-19.24M
37.30%-16.36M
-6.11%-20.13M
-63.65%-26.41M
-7.97%-22.05M
-15.06%-26.10M
-0.12%-18.97M
20.85%-16.14M
42.58%-20.42M
40.23%-22.68M
42.70%-18.95M
31.02%-20.39M
-28.18%-35.56M
-10.68%-37.95M
-53.40%-33.07M
-38.99%-29.57M
Net Profit
-153.47%-23.04M
75.80%-19.88M
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.95M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
-28.69%-35.62M
-9.57%-37.71M
0.52%-33.12M
-43.38%-29.82M
Current assets
-58.36%59.63M
33.35%82.86M
29.58%103.44M
28.50%127.94M
21.29%143.21M
-55.95%62.14M
6.94%79.82M
5.65%99.57M
7.89%118.06M
5.65%141.08M
-50.27%74.64M
-43.80%94.24M
-43.90%109.43M
-34.67%133.54M
-39.64%150.09M
-14.73%167.69M
-11.26%195.08M
-18.24%204.42M
237.44%248.67M
115.02%196.64M
Total current liabilities
23.08%23.32M
-2.32%21.23M
4.92%21.99M
-14.00%20.27M
0.36%18.95M
-9.07%21.74M
-6.73%20.96M
-13.45%23.56M
-32.76%18.88M
-27.84%23.91M
-26.43%22.47M
-13.99%27.23M
-32.10%28.08M
-14.96%33.13M
-12.19%30.54M
5.17%31.65M
63.91%41.36M
28.68%38.96M
74.04%34.78M
95.90%30.10M
Total assets
-57.16%64.56M
26.31%88.53M
24.13%109.76M
23.80%134.71M
17.82%150.70M
-53.74%70.09M
3.00%88.43M
2.53%108.81M
5.06%127.90M
3.30%151.53M
-47.67%85.85M
-41.85%106.13M
-42.16%121.74M
-37.68%146.69M
-37.63%164.07M
-13.85%182.52M
-10.26%210.47M
-11.28%235.37M
185.38%263.07M
96.36%211.88M
Total liabilities
-4.34%32.77M
-64.68%34.99M
-1.04%37.93M
-21.02%32.84M
-49.70%34.25M
66.65%99.07M
23.52%38.33M
13.94%41.58M
84.13%68.11M
38.92%59.45M
-26.22%31.03M
-19.87%36.49M
-35.77%36.99M
-15.49%42.79M
-8.69%42.06M
5.93%45.54M
46.45%57.58M
11.88%50.64M
-0.49%46.06M
43.75%42.99M
Total equity
-72.70%31.79M
284.81%53.55M
43.39%71.83M
51.52%101.87M
94.74%116.44M
-131.47%-28.97M
-8.62%50.10M
-3.46%67.23M
-29.44%59.80M
-11.38%92.08M
-55.07%54.82M
-49.16%69.64M
-44.57%84.75M
-43.76%103.90M
-43.78%122.01M
-18.89%136.98M
-21.69%152.89M
-16.05%184.73M
372.81%217.01M
116.54%168.88M
Net operating income
-10.61%-23.13M
-18.16%-21.75M
-21.11%-24.34M
20.46%-15.50M
8.08%-20.91M
18.78%-18.40M
1.16%-20.10M
-43.16%-19.49M
-1.60%-22.75M
-35.01%-22.66M
-18.67%-20.34M
45.61%-13.62M
-9.56%-22.39M
55.22%-16.78M
32.45%-17.14M
-8.76%-25.04M
31.42%-20.43M
-90.41%-37.48M
---25.37M
-30.09%-23.02M
Net investment
179.27%34.93M
-110.12%-2.02M
358.58%47.68M
-198.57%-39.42M
50.29%-44.07M
285414.29%19.97M
115633.33%10.40M
59.95%39.99M
-543.37%-88.64M
-100.06%-7.00K
-100.03%-9.00K
350.64%25.00M
133.10%19.99M
170.42%11.60M
81307.50%32.48M
-201.30%-9.98M
-723.17%-60.40M
-210.32%-16.48M
---40.00K
-34.04%9.85M
Net financing
-100.06%-62.00K
26.80%123.00K
-1225.00%-53.00K
-162.99%-177.00K
535584.21%101.74M
-99.89%97.00K
80.95%-4.00K
-32.13%281.00K
-1800.00%-19.00K
72574.38%87.94M
-10.53%-21.00K
398.80%414.00K
95.24%-1.00K
-78.08%121.00K
-100.02%-19.00K
-12.63%83.00K
-126.92%-21.00K
-99.71%552.00K
--77.95M
251.85%95.00K

FAQs

What is the total revenue of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its total revenue reached 2.19M, with a year-on-year change of 3.94M.

What are the current assets of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its current assets were 82.86M, with a year-on-year change of 33.35.

What are the total assets of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its total assets of Aligos Therapeutics Inc were 88.53M, with a year-on-year change of 26.31.

What are the total liabilities of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its total liabilities of Aligos Therapeutics Inc were 34.99M, with a year-on-year change of -64.68.

What is the total equity of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its total equity of Aligos Therapeutics Inc was 53.55M, with a year-on-year change of 284.81.

What is the net operating income of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its net operating income of Aligos Therapeutics Inc was -87.98M, with a year-on-year change of -3.57.

What is the net investment of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its net investment of Aligos Therapeutics Inc was -37.83M, with a year-on-year change of -106.94.

What is the net financing of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its net financing of Aligos Therapeutics Inc was 101.64M, with a year-on-year change of 28529.58.

What is the Earnings Per Share (EPS) of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.45, with a year-on-year change of 88.31.

What is the net income of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its net income was -24.19M, with a year-on-year change of 81.56.

What is the net margin of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its net profit margin was -1106.72, with a year-on-year change of 66.73.

What is the debt-to-asset ratio of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 0.16, with a year-on-year change of -27.34.

What is the Return on Equity (ROE) of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -196.92, with a year-on-year change of 52.65.

What is the Return on Assets (ROA) of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -30.50, with a year-on-year change of 74.24.

What is the operating profit of Aligos Therapeutics Inc?

According to Aligos Therapeutics Inc's FY2025 earnings report, its operating profit was -87.98M, with a year-on-year change of -3.57.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.